This study presents novel methodology for pandemic risks assessment for a national health system of interest. The 2019 coronavirus disease (COVID-19) is a contagious disease with certain potential for worldwide spread and potentially significant
CONCLUSION: Current real-world efficacy evidence indicates that dupilumab reduces asthma exacerbations and total SCS prescriptions in clinical practice. The effectiveness of dupilumab was observed independent of exacerbation history, EOS levels, or
False-positive fourth-generation HIV screening tests are rare and are usually associated with various infections and autoimmune diseases. SARS-CoV-2 infection and vaccination were recently linked with false-positive HIV screening test results
This dataset was created with the primary objective of elucidating the intricate relationship between the incidence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) re-infections and the pre-illness vaccination profile and types
CONCLUSION: This study found a high prevalence of COVID-19 fear among Chinese MHPs following the end of China's Dynamic Zero-COVID Policy. Developing effective prevention and intervention measures that target the central symptoms as well as symptoms
Background: The recent COVID-19 pandemic dramatically underlined the multi-faceted nature of health research, requiring input from basic biological sciences, pharmaceutical technologies, clinical research), social sciences and public health and
CONCLUSION: This study reveals that critically ill patients infected with different Omicron BA.5.2 subvariants experience similar levels of cellular immune dysfunction and inflammatory response. Four mutations - ORF1a:K3353R, ORF1a:L3667F, ORF1b
CONCLUSION: The COVID-19 infection status and symptoms around infection have no statistical difference in anxiety level and general well-being after they experience the COVID-19 pandemic. However, through this study, we found some influencing factors